Persistent Misperceptions about Nicotine among US Physicians: Results from a Randomized Survey Experiment.

What Was Tested

This randomized controlled trial looks at Therapeutic nicotine (patch, non-peptide).

The researchers conducted a survey experiment among US physicians to evaluate whether question wording impacted perceptions about the health effects of nicotine. 926 physicians were randomized to receive one of two versions of a question matrix that asked about the "extent to which they agree or disagree that 'nicotine' (Version 1) or 'nicotine, on its own,' (Version 2) directly contributes to" birth defects, cardiovascular disease (CVD), cancer, depression, and chronic obstructive pulmonary disease (COPD).

Why It Was Studied

The researchers evaluated whether question condition predicted strong agreement and/or agreement with each statement, and assessed demographic correlates of each outcome while adjusting for question version.

Who Took Part

PubMed tags the participants as women only.

How the Study Was Run

The design is described as randomized.

Because people in this Therapeutic nicotine (patch, non-peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

What Was Measured

The researchers evaluated whether question condition predicted strong agreement and/or agreement with each statement, and assessed demographic correlates of each outcome while adjusting for question version.

The subject headings attached to it are Nicotine, Physicians, Family, Prevalence, Pulmonary Disease, Chronic Obstructive and Surveys and Questionnaires.

The authors tagged it with the keywords perceptions.

What This Means in Plain Language

The paper is a randomized study of Therapeutic nicotine (patch, non-peptide).

The publication is from 2021 (International journal of environmental research and public health), a journal based in Switzerland.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.